Kahn Brothers Kahn Brothers Group
Kahn Brothers Group is a value investment firm founded in the tradition of Benjamin Graham and long associated with the Kahn family of investors. The firm is known for deep-value security analysis, patience, and a multi-decade orientation to intrinsic value. Its filings are followed by classic value investors seeking Graham-and-Dodd style managers still active in public markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Patterson-UTI
PTEN
|
+$9.71M |
| 2 |
BP
BP
|
+$6.72M |
| 3 |
Assured Guaranty
AGO
|
+$2.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$9.03M |
| 2 |
Merck
MRK
|
+$8.24M |
| 3 |
GSK
GSK
|
+$1.05M |
| 4 |
MBIA
MBI
|
+$940K |
| 5 |
Seaboard Corp
SEB
|
+$787K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.27% |
| 2 | Financials | 30.51% |
| 3 | Energy | 11.12% |
| 4 | Technology | 8.43% |
| 5 | Consumer Staples | 6.22% |
Similar funds
Kahn Brothers's Q2 2020 Portfolio in Review
As of Q2 2020, Kahn Brothers held 48 positions worth $592M, up 8.2% from $547M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 2.1%. Kahn Brothers opened no new positions and exited 1, leaving the 48-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 42% a quarter earlier, followed by Financials and Energy.
- Kahn Brothers added most to Patterson-UTI in Q2 2020, an estimated $9.71M increase.
- Kahn Brothers's biggest Q2 2020 reduction was Hologic, cutting an estimated $9.03M.
- Kahn Brothers fully exited Alcon in Q2 2020, selling an estimated $202K.
- Kahn Brothers's ten largest holdings make up 81% of its $592M portfolio in Q2 2020.
- Kahn Brothers opened 0 new positions and closed 1 in Q2 2020.
- Kahn Brothers's portfolio value rose 8.2% quarter-over-quarter to $592M.
Based on Kahn Brothers Group's 13F filing for Q2 2020, filed 3 Aug 2020.